MILLER MARK THOMAS,ANDERSON COREY,ARUMUGAM VIJAYALAKSMI,BEAR BRIAN RICHARD,BINCH HAYLEY MARIE,CLEMENS JEREMY J,CLEVELAND THOMAS,CONROY ERICA,COON TIMOTHY RICHARD,FRIEMAN BRYAN A,GROOTENHUIS PETER DIED
申请号：
IN201737015848
公开号：
IN201737015848A
申请日:
2017.05.05
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The present invention features a compound of formula (I): (I) or a pharmaceutically acceptable salt thereof where R1, R2, R3, W, X, Y, Z n, o, p and q are defined herein for the treatment of CFTR mediated diseases such as cystic fibrosis. The present invention also features pharmaceutical compositions method of treating and kits thereof.
